Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06465745 · ClinicalTrials.gov registry record · NA
AltaValve Pivotal Trial
A NA study of Mitral Regurgitation and Mitral Valve Regurgitation, sponsored by 4C Medical Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 20
- Study locations
NCT06465745: Recruiting NA study of Mitral Regurgitation and Mitral Valve Regurgitation, sponsored by 4C Medical Technologies.
NCT06465745 is a NA study of Mitral Regurgitation and Mitral Valve Regurgitation that is actively recruiting participants, run by 4C Medical Technologies. The registered enrollment target is 450 participants, below the 1,007-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (55% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06465745, a NA study of Mitral Regurgitation and Mitral Valve Regurgitation, is actively recruiting participants, sponsored by 4C Medical Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.
Conditions Studied
Interventions
- DEVICE AltaValve System.
Study Locations (20)
Arizona
- Abrazo Arizona Heart Hospital - Phoenix
- Dignity Health; St. Joseph's Hospital and Medical Center - Phoenix
- TMC Healthcare - Tucson
California
- Sutter Bay Hospitals - San Francisco
- Los Robles Hospital & Medical Center - Thousand Oaks
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
- Mayo Clinic - Rochester
New York
- New York Presbyterian Hospital-Columbia University Medical Center - New York
- Montefiore Medical Center - The Bronx
Louisiana
- Cardiovascular Institute of the South - Houma
Maryland
- MedStar Health Research Institute, Inc. - Columbia
Michigan
- William Beaumont Hospital - Royal Oak
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-09-03 |
| Est. Completion | 2031-09 |
| Phase | NA |
What NCT06465745 shows while recruiting
NCT06465745 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,007-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (55% lower).
The record links to 5 conditions, with Mitral Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which AltaValve System. is the first listed.
NCT06465745 names 20 study sites across 15 states, led by Arizona, California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06465745 about?
NCT06465745 is a clinical study titled "AltaValve Pivotal Trial". This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.
What is the current status of trial NCT06465745?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2024-09-03. Estimated completion is 2031-09.
What conditions does trial NCT06465745 study?
This clinical trial studies the following conditions: Mitral Regurgitation, Mitral Valve Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Incompetence.
What interventions are being tested in trial NCT06465745?
The interventions under investigation include: AltaValve System. (DEVICE).
Who is sponsoring clinical trial NCT06465745?
This trial is sponsored by 4C Medical Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06465745 being conducted?
This trial has 20 study locations across Arizona, California, Louisiana, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06465745's enrollment target sits among peer trials
450 11th of 26 higher than 16 of 26 other Mitral Regurgitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mitral Regurgitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
RECRUITING · NA
-
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
RECRUITING · NA
-
EFS of the CardioMech MVRS
RECRUITING · NA
-
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
RECRUITING · NA
-
Cephea Early Feasibility Study
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI